Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT03674775
NA

Reducing Antibiotic Prescribing in Family Practice

Sponsor: Seattle Children's Hospital

View on ClinicalTrials.gov

Summary

Antibiotic prescribing for childhood acute respiratory tract infections (ARTIs), including acute otitis media (AOM), pharyngitis, sinusitis, bronchitis, and upper respiratory infection (URI), is common in the United States (US). In the outpatient setting, more than 50% of children diagnosed with ARTIs receive antibiotic prescriptions. Considering that the estimated US prevalence of pediatric bacterial ARTIs is 27% (with the remainder of ARTIs caused by viruses) this represents a substantial degree of antibiotic overuse nationwide. Another troubling trend in antibiotic prescribing for ARTIs in children is the increased reliance on broad-spectrum, second-line agents for bacterial ARTIs. Unwarranted use of antibiotics, especially broad-spectrum agents, has been associated with increased resistance among several strains of bacteria that commonly cause ARTIs, posing risks to both individuals and communities.

Official title: Dialogue Around Respiratory Illness Treatment for Family Practice (DART -FP)

Key Details

Gender

All

Age Range

6 Months - Any

Study Type

INTERVENTIONAL

Enrollment

180

Start Date

2022-07

Completion Date

2026-06

Last Updated

2019-09-19

Healthy Volunteers

No

Interventions

OTHER

DART QI Program Participation

Antibiotic prescribing data will be collected at multiple time points both before and after the initiation of the intervention.